1. Elhai M et al. Ann Rheum Dis 2017;76:1897–905.
2. Distler O et al. N Engl J Med 2019;380:2518–28.
3. Goh NS et al. Am J Respir Crit Care Med 2008;177:1248–54.
4. Hoffmann-Vold AM et al. Am J Respir Crit Care Med 2019;200:1258–66.

The SENSCIS trial was funded by Boehringer Ingelheim. Editorial and formatting assistance, supported financially by Boehringer Ingelheim, was provided by Elizabeth Ng and Wendy Morris of FleishmanHillard Fishburn, London, UK during preparation of this poster. The authors were fully responsible for all content and editorial decisions, were involved at all stages of poster development and have approved the final version. Boehringer Ingelheim was given the opportunity to review the poster for medical and scientific accuracy as well as intellectual property considerations. The authors received no direct compensation related to the development of this poster. Nicole Goh has no conflicts of interest to disclose. Athol Wells reports personal fees from Blade Therapeutics, Boehringer Ingelheim, and InterMune/Roche.